1-deoxynojirimycin has been researched along with Autosomal Dominant Hereditary Spastic Paraplegia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Platt, FM; Rahim, AA; Ridley, CM; Shanahan, J; Shen, A; Thillaiappan, NB; Thur, KE; Uhl, K; van der Spoel, AC; Waddington, SN; Walden, CM | 1 |
1 other study(ies) available for 1-deoxynojirimycin and Autosomal Dominant Hereditary Spastic Paraplegia
| Article | Year |
|---|---|
β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
Topics: 1-Deoxynojirimycin; Animals; beta-Glucosidase; Cell Line, Tumor; Cerebellar Ataxia; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Mice; Spastic Paraplegia, Hereditary | 2013 |